| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D411-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D411-04 |
| filingDate |
2011-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d471dd6e518c3a8483b2d3dd8aefd3f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ececedb1971500ebc6aedde4d0ab0cd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6224483ca1f482f3a6f773cbb06cf941
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_988c5a384970320ad78c8a8b394c1e84 |
| publicationDate |
2013-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2542551-A1 |
| titleOfInvention |
A process for stereoselective synthesis of 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine |
| abstract |
The present invention provides an improved process for stereoselective preparation of 5-fluoro-l-(2R,5S)-[2-(hydroxymethyl)-l,3-oxathiolan-5-yl]cytosine and pharmaceutically acceptable salts thereof. |
| priorityDate |
2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |